Tizanidine Hydrochloride Capsule
Product Images NDC 71335-2559

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 71335-2559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352559)

Label for tizanidine hydrochloride 4 mg capsules from Bryant Ranch Prepack. The label shows the NDC 71335-2559-1, with storage instructions, QR codes for prescribing information and package insert, and manufacturer details listed as Rubicon Research Private Limited. The package contains 1 capsule in child-resistant packaging.*

FDA Label Image

Figure 1 (Tizanidine Hydrochloride Capsules Figure 1)

A line graph showing plasma tizanidine concentration (ng/mL) over time (hours) after dosing. It compares four conditions: 2 x 4 mg tizanidine tablets with food, 2 x 4 mg tizanidine tablets without food, 2 x 4 mg tizanidine capsules with food, and 2 x 4 mg tizanidine capsules without food. Concentrations peak between 1 and 2 hours and then decline to near zero by 10 hours after dosing.*

FDA Label Image

Figure 2 (Tizanidine Hydrochloride Capsules Figure 2)

A line graph depicting improvement in Ashworth Score over hours post-dose comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis shows improvement score, and the x-axis shows time in hours up to 6 hours post-dose, with different lines representing each treatment group.*

FDA Label Image

Figure 3 (Tizanidine Hydrochloride Capsules Figure 3)

A line graph comparing improvement in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo groups at three different time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). Tizanidine shows higher improvement scores with error bars, while placebo scores remain near zero with respective error bars.*

FDA Label Image

Chemical Structural Formula (Tizanidine Hydrochloride Capsules Structure)

Chemical structure of tizanidine hydrochloride, showing a chlorinated benzothiazole ring connected to an imidazoline moiety, labeled with HCl indicating the hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.